We are scientists fighting the burden of major acute respiratory virus infections by fostering stakeholder communication and cross-disciplinary research in Europe.

News

ESWI activities

9th influenza conference 2023
17 - 20 September 2023
Valencia
ESWI Airborne
Meet the members in the podcast series ESWI Airborne. These educational and captivating talks give an insight into the fascinating world of respiratory viruses moderated by our host Clare Taylor.
ESWI webinar series 2021
How can countries cope with more than one major respiratory virus spreading, while non- pharmaceutical interventions are being loosened week by week?
ESWI Summit 2022
21 June 2022
Brussels & Online

Agenda

2022
7-11
October
9th Congress of the European Academy of Paediatric Societies
Barcelona & online
2022
7-8
October
ME'NA-ISN Influenza Day 2022
Istanbul
2022
11-14
October
World Vaccine Congress Europe 2022
Barcelona
2022
12
October
Making influenza vaccination a priority across Europe
Online
The Steering Group on Influenza Vaccination is organising the third annual EU Flu Day to raise awareness on the need for better protection against seasonal influenza for European citizens and health systems.
2022
7-11
November
7th World One Health Congress
Singapore
The 7th World One Health Congress will take place in Singapore in 2022, bringing together experts from around the world to share learnings across diverse disciplines in a five-day hybrid event at the Sands Convention Centre.
2022
17-20
November
International Congress for Infectious Diseases Congress 2022
Kuala Lumpur
The International Society for Infectious Diseases (ISID) will hold its next in-person and virtual International Congress on Infectious Diseases November 17–20, 2022 in Kuala Lumpur, Malaysia.

Education hub

News
“Flu, COVID and RSV: How to vaccinate?” symposium at Options XI
30 years of ESWI
Scientific Papers
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
As 2019 turned into 2020, a coronavirus spilled over from wild animals into people, sparking what has become one of the best documented pandemics to afflict humans.
Scientific Papers
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
The COVID-19 pandemic has been ongoing for more than 2 years now, and new variants such as Omicron are less susceptible to the vaccines developed against earlier lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientific Papers
Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymerase
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory infections in infants and the immunocompromised, yet no efficient therapeutic exists. We have identified the AVG class of allosteric inhibitors of RSV RNA synthesis.

ESWI networks & communities

Influenza Diabetes Community

The Influenza Diabetes Community (IDC) unites scientists, healthcare professionals, patient -and other stakeholder organisations to discuss, share best practices and to network with the objective to raise awareness of the burden of influenza, Covid-19 and RSV in people living with diabetes.

Young Scientists Network

Some of the best and most innovative ideas come from young scientists, and young scientists are the future of the influenza field. For this reason, ESWI has been actively encouraging the careers of young scientists for many years.